7-26193569-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_002137.4(HNRNPA2B1):c.841+6A>G variant causes a splice donor region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00104 in 1,578,182 control chromosomes in the GnomAD database, including 16 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0058 ( 10 hom., cov: 32)
Exomes 𝑓: 0.00054 ( 6 hom. )
Consequence
HNRNPA2B1
NM_002137.4 splice_donor_region, intron
NM_002137.4 splice_donor_region, intron
Scores
2
Splicing: ADA: 0.0004119
2
Clinical Significance
Conservation
PhyloP100: -0.143
Genes affected
HNRNPA2B1 (HGNC:5033): (heterogeneous nuclear ribonucleoprotein A2/B1) This gene belongs to the A/B subfamily of ubiquitously expressed heterogeneous nuclear ribonucleoproteins (hnRNPs). The hnRNPs are RNA binding proteins and they complex with heterogeneous nuclear RNA (hnRNA). These proteins are associated with pre-mRNAs in the nucleus and appear to influence pre-mRNA processing and other aspects of mRNA metabolism and transport. While all of the hnRNPs are present in the nucleus, some seem to shuttle between the nucleus and the cytoplasm. The hnRNP proteins have distinct nucleic acid binding properties. The protein encoded by this gene has two repeats of quasi-RRM domains that bind to RNAs. This gene has been described to generate two alternatively spliced transcript variants which encode different isoforms. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.58).
BP6
Variant 7-26193569-T-C is Benign according to our data. Variant chr7-26193569-T-C is described in ClinVar as [Benign]. Clinvar id is 541429.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr7-26193569-T-C is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00575 (876/152288) while in subpopulation AFR AF= 0.0198 (822/41546). AF 95% confidence interval is 0.0187. There are 10 homozygotes in gnomad4. There are 417 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 876 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HNRNPA2B1 | NM_002137.4 | c.841+6A>G | splice_donor_region_variant, intron_variant | ENST00000618183.5 | NP_002128.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HNRNPA2B1 | ENST00000618183.5 | c.841+6A>G | splice_donor_region_variant, intron_variant | 5 | NM_002137.4 | ENSP00000478691 | A1 |
Frequencies
GnomAD3 genomes AF: 0.00575 AC: 875AN: 152170Hom.: 9 Cov.: 32
GnomAD3 genomes
AF:
AC:
875
AN:
152170
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00165 AC: 360AN: 217804Hom.: 6 AF XY: 0.00125 AC XY: 148AN XY: 118416
GnomAD3 exomes
AF:
AC:
360
AN:
217804
Hom.:
AF XY:
AC XY:
148
AN XY:
118416
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000538 AC: 767AN: 1425894Hom.: 6 Cov.: 31 AF XY: 0.000477 AC XY: 338AN XY: 708570
GnomAD4 exome
AF:
AC:
767
AN:
1425894
Hom.:
Cov.:
31
AF XY:
AC XY:
338
AN XY:
708570
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00575 AC: 876AN: 152288Hom.: 10 Cov.: 32 AF XY: 0.00560 AC XY: 417AN XY: 74470
GnomAD4 genome
AF:
AC:
876
AN:
152288
Hom.:
Cov.:
32
AF XY:
AC XY:
417
AN XY:
74470
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inclusion body myopathy with early-onset Paget disease with or without frontotemporal dementia 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 28, 2019 | - - |
HNRNPA2B1-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 19, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at